|
TMEM199 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.50400000000462E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.764440E-04 |
| Normal-vs-Stage2 |
8.724400E-01 |
| Normal-vs-Stage3 |
4.21949999995785E-06 |
| Normal-vs-Stage4 |
1.2553999995113E-07 |
| Stage1-vs-Stage2 |
1.164010E-02 |
| Stage1-vs-Stage3 |
1.662230E-01 |
| Stage1-vs-Stage4 |
6.264600E-03 |
| Stage2-vs-Stage3 |
1.962970E-03 |
| Stage2-vs-Stage4 |
8.19770000000108E-05 |
| Stage3-vs-Stage4 |
1.014420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75480999999866E-05 |
| Normal-vs-AfricanAmerican |
6.623500E-03 |
| Normal-vs-Asian |
7.481000E-03 |
| Caucasian-vs-AfricanAmerican |
9.742000E-01 |
| Caucasian-vs-Asian |
5.302600E-01 |
| AfricanAmerican-vs-Asian |
7.111600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44770000052053E-07 |
| Normal-vs-Female |
1.000340E-03 |
| Male-vs-Female |
5.764000E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.973500E-04 |
| Normal-vs-Age(41-60Yrs) |
4.448500E-04 |
| Normal-vs-Age(61-80Yrs) |
3.356100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.712200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.631600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.093400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.363600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.102400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.282400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.910000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.531790E-02 |
| Classical-VS-Follicular |
1.071160E-01 |
| Classical-VS-Other |
5.358500E-02 |
| Classical-VS-Normal |
4.40600000000124E-05 |
| Tall-VS-Follicular |
2.457800E-03 |
| Tall-VS-Other |
4.503000E-01 |
| Tall-VS-Normal |
9.09780000002414E-07 |
| Follicular-VS-Other |
6.744100E-02 |
| Follicular-VS-Normal |
8.343500E-02 |
| Other-VS-Normal |
1.617900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.240270E-02 |
| Normal-vs-N1 |
2.00259999999508E-05 |
| N0-vs-N1 |
9.136700E-03 |
|
|
